Table 4 Other adverse events
From: Real-world evidence of galcanezumab for migraine treatment in Japan: a retrospective analysis
Adverse event | n (%) |
|---|---|
Constipation | 4 (7.7) |
Fatigue | 3 (5.8) |
Burning sensation | 2 (3.8) |
Lightheadedness | 2 (3.8) |
Urticaria | 1 (1.9) |
Loss of hair | 1 (1.9) |
Stiffness in the leg | 1 (1.9) |
Chills | 1 (1.9) |
Eczema | 1 (1.9) |
Elevated blood pressure | 1 (1.9) |
Menstrual irregularity | 1 (1.9) |
Back pain | 1 (1.9) |
Somnolence | 1 (1.9) |
Headache | 1 (1.9) |